Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,265 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,265 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,265 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,265 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,265 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,265 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,265 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
9 Mar 2026
Crews Terrell Kirk II EVP, Chief Risk Officer
Sold on a plan 3×
$1.78M 19,672 at 90.27
21.0%
Planned (10b5-1)
9 Mar 2026
Dill Julie Director
Sold on a plan
$1.73M 4,500 at 384.28
20.1%
Planned (10b5-1)
9 Mar 2026
Ragosa Mark CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$1.69M 36,722 at 45.92
75.2%
Sold half or more
9 Mar 2026
Moore Stephanie Zapata EVP and General Counsel
Sold on a plan
$1.60M 10,000 at 160.31
8.0%
Planned (10b5-1)
9 Mar 2026
Meloy Charles Alvin Director · indirect
Sold on a plan 7×
$1.44M 7,857 at 183.27
0.8%
Planned (10b5-1)
9 Mar 2026
Slowe Christopher Brian Chief Technology Officer
Sold on a plan 6×
$1.30M 9,500 at 136.55
4.9%
Planned (10b5-1)
9 Mar 2026
Wu Lei Chief Executive Officer · indirect
Sold on a plan 4×
$1.26M 30,000 at 42.13
8.3%
Planned (10b5-1)
9 Mar 2026
Farrell Michael J. Chairman and CEO
Sold on a plan
$1.25M 4,991 at 251.03
1.1%
Planned (10b5-1)
9 Mar 2026
Keeney Scott H President and CEO
Sold on a plan 5×
$1.12M 19,096 at 58.80
0.9%
Planned (10b5-1)
9 Mar 2026
Hunsaker Craig E EVP, PEOPLE & CULTURE
Sold on a plan
$1.03M 82,765 at 12.45
4.6%
Planned (10b5-1)
9 Mar 2026
Tan Kwang Hooi Chief Operating Officer
Sold on a plan
$1.03M 17,500 at 58.87
7.0%
Planned (10b5-1)
9 Mar 2026
Morris John J President & COO
Sold on a plan
$1.02M 4,211 at 243.38
4.0%
Planned (10b5-1)
9 Mar 2026
Mehrotra Parth Chief Executive Officer
Sold on a plan 3×
$959.90K 41,999 at 22.86
10.9%
Planned (10b5-1)
9 Mar 2026
Du Ying Chairperson & CEO
Sold on a plan
$951.47K 50,000 at 19.03
4.9%
Planned (10b5-1)
9 Mar 2026
Collins Helen Louise CHIEF MEDICAL OFFICER
Sold on a plan
$896.81K 29,871 at 30.02
54.4%
Sold half or more
9 Mar 2026
SKAGGS STEPHEN A Director
Sold on a plan
$856.55K 3,523 at 243.13
17.3%
Planned (10b5-1)
9 Mar 2026
Bergman Artur Chief Technology Officer · indirect
Sold on a plan 3×
$842.95K 40,000 at 21.07
2.1%
Planned (10b5-1)
9 Mar 2026
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$763.66K 10,148 at 75.25
14.0%
Planned (10b5-1)
9 Mar 2026
Mazumdar Claire Chief Executive Officer
Sold on a plan
$704.66K 36,766 at 19.17
9.8%
Planned (10b5-1)
9 Mar 2026
Brooks Cameron CHIEF REVENUE OFFICER
Sold on a plan
$690.49K 1,221 at 565.51
2.1%
Planned (10b5-1)
9 Mar 2026
May James Michael Treasurer and Asst. Secretary
Sold on a plan 2×
$646.42K 7,161 at 90.27
21.1%
Planned (10b5-1)
9 Mar 2026
Frost Bert A EVP, Chief Commercial Officer
Sold on a plan
$643.11K 5,534 at 116.21
6.3%
Planned (10b5-1)
9 Mar 2026
Olivan Javier Chief Operating Officer
Sold on a plan
$587.95K 926 at 634.94
5.7%
Planned (10b5-1)
9 Mar 2026
Bayview Legacy, LLC 10% owner · indirect
Sold on a plan
$582.63K 41,000 at 14.21
0.4%
Planned (10b5-1)
9 Mar 2026
JANAC K CHARLES President and CEO · indirect
Sold on a plan
$582.63K 41,000 at 14.21
0.4%
Planned (10b5-1)
9 Mar 2026
GORDON WILLIAM B Director
Sold on a plan
$521.73K 2,500 at 208.69
4.2%
Planned (10b5-1)
9 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$457.62K 30,941 at 14.79
4.6%
Planned (10b5-1)
9 Mar 2026
Sedgwick Karen L Executive VP and CFO
Sold on a plan 3×
$451.04K 4,872 at 92.58
11.1%
Planned (10b5-1)
9 Mar 2026
Light David SVP & Chief Accounting Officer
Sold on a plan
$413.41K 6,622 at 62.43
57.0%
Sold half or more
9 Mar 2026
Olivan Javier Chief Operating Officer · indirect
Sold on a plan 4×
$399.38K 629 at 634.94
18.5%
Planned (10b5-1)
9 Mar 2026
Blake Sarah SVP, Chief Accounting Officer
Sold on a plan
$399.21K 30,700 at 13.00
100%
Sold half or more
9 Mar 2026
Goel Rajeev K. CHIEF EXECUTIVE OFFICER
Sold on a plan
$383.81K 44,000 at 8.72
100%
Sold half or more
9 Mar 2026
Davis Krista SVP, CHIEF HR OFFICER
Sold on a plan
$377.10K 5,087 at 74.13
8.9%
Planned (10b5-1)
9 Mar 2026
Zedelmayer Christine Sr. Vice President and COO
Sold on a plan
$362.44K 181,219 at 2.00
74.3%
Sold half or more
9 Mar 2026
Lemasney Mark EVP Power Generation Division
Sold on a plan
$347.09K 3,845 at 90.27
29.9%
Planned (10b5-1)
9 Mar 2026
Brosius Mark SVP & Chief Mfg and Supply Cha
Sold on a plan
$312.83K 645 at 485.01
28.6%
Planned (10b5-1)
9 Mar 2026
Breeden John E Chief Delivery Officer
Sold on a plan
$312.00K 6,076 at 51.35
6.7%
Planned (10b5-1)
9 Mar 2026
Taira Thomas President, Special Projects
Sold on a plan
$309.73K 953 at 325.00
1.4%
Planned (10b5-1)
9 Mar 2026
Santana Rafael President and CEO
Sold on a plan 9×
$282.73K 1,163 at 243.10
0.6%
Planned (10b5-1)
9 Mar 2026
Mutz Christopher HEAD OF RARE DISEASE
Sold on a plan
$267.20K 3,602 at 74.18
3.7%
Planned (10b5-1)
9 Mar 2026
Foley Douglas SVP, HR & Administration
Sold on a plan
$263.94K 1,600 at 164.96
5.7%
Planned (10b5-1)
9 Mar 2026
Dieter David EVP & General Counsel
Sold on a plan
$228.11K 6,224 at 36.65
6.4%
Planned (10b5-1)
9 Mar 2026
Rutledge Kimberly Anne Chief People Officer
Sold on a plan
$222.86K 4,340 at 51.35
4.9%
Planned (10b5-1)
9 Mar 2026
Brown Shona L Director
Sold on a plan
$220.76K 1,250 at 176.61
3.9%
Planned (10b5-1)
9 Mar 2026
Jones Eifion Senior Vice President and CFO
Sold on a plan
$218.55K 15,000 at 14.57
4.5%
Planned (10b5-1)
9 Mar 2026
Dun Haiping Director
Sold on a plan 2×
$217.36K 5,000 at 43.47
100%
Sold half or more
9 Mar 2026
Lucas Shannon President & COO · indirect
Sold on a plan
$213.29K 11,700 at 18.23
0.7%
Planned (10b5-1)
9 Mar 2026
Rosenbaum Michael George Chief Executive Officer
Sold on a plan
$199.61K 1,200 at 166.34
0.5%
Planned (10b5-1)
9 Mar 2026
KANE CHARLES Director
Sold on a plan 4×
$191.43K 4,000 at 47.86
4.3%
Planned (10b5-1)
9 Mar 2026
COGHLAN JOHN PHILIP Director · indirect
Sold on a plan 2×
$184.66K 4,000 at 46.17
44.1%
Planned (10b5-1)
Showing 15,001–15,050 of 23,265. ← Newer Page 301 of 466 Older →